Form 483

Batzofin Fertility Services Form 483, 2019-04-29

FDA issued a Form 483 to Batzofin Fertility Services on 2019-04-29 with 10 public-safe observations.

483· Form 483 issuedBiologics10 observations

Batzofin Fertility Services · New York, United States · Issued April 29, 2019

Overview

  • 10 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Apr 2019
21 CFR 1271.47(a)

Donor eligibility procedures

Cited by Irina Gaberman

29 Apr 2019
21 CFR 1271.47(a)

Donor eligibility procedures

Cited by Irina Gaberman

29 Apr 2019
21 CFR 1271.50(b)(1)

Donor screening standards

Cited by Irina Gaberman

29 Apr 2019
21 CFR 1271.50(b)(1)

Donor screening standards

Cited by Irina Gaberman

29 Apr 2019
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Irina Gaberman

Inspected site

BFBatzofin Fertility ServicesNew York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations4x
21 CFR 1271.50(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 1271.80(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 10 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere